Biocept Inc. buy klostergang
Start price
01.07.15
/
50%
€81,567
Target price
07.12.15
€81,000
Performance (%)
-48.63%
End price
07.12.15
€41,904
Summary
This prediction ended on 07.12.15 with a price of €41,904. The BUY prediction by klostergang for Biocept Inc. performed very badly with a performance of -48.63%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biocept Inc. | - | - | - | - |
| iShares Core DAX® | 0.985% | 8.314% | 7.032% | 49.791% |
| iShares Nasdaq 100 | 2.067% | 16.765% | 35.952% | 96.632% |
| iShares Nikkei 225® | 2.270% | 15.605% | 46.568% | 69.047% |
| iShares S&P 500 | 1.043% | 11.077% | 26.456% | 68.087% |
Comments by klostergang for this prediction
In the thread Biocept Inc. diskutieren
An emerging player in the liquid biopsy space :
Biocept Inc is a cancer diagnostics company that develops and commercializes proprietary circulating tumor cell, or CTC, and circulating tumor DNA, or ctDNA, tests utilizing a standard blood sample or liquid biopsy.
(Vom Mitglied beendet)